Monitoring the Response of Combination Ursodiol and Seladelpar Treatment

Study of Seladelpar in Participants With Primary Biliary Cholangitis (PBC)

NCT03301506 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Ursodiol-Methotrexate for Primary Biliary Cirrhosis

NCT00006168 ·Status: COMPLETED ·Phase: PHASE3

Phase III Randomized Study of Ursodiol With Vs Without Methotrexate for Primary Biliary Cirrhosis

NCT00004784 ·Status: COMPLETED ·Phase: PHASE3

Study to Assess Safety & Efficacy of GKT137831 in Patients With Primary Biliary Cholangitis Receiving Ursodiol.

NCT03226067 ·Status: COMPLETED ·Phase: PHASE2

Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary Cholangitis

NCT05749822 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

A Multicenter, Randomized, Controlled Trial of Prednisone Combined With Ursodeoxycholic Acid in the Treatment of Primary Biliary Cholangitis With Moderate to Severe Interface Hepatitis Characteristics

NCT06591468 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2/PHASE3

Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis

NCT06051617 ·Status: RECRUITING ·Phase: PHASE3

Fenofibrate Combined With Ursodeoxycholic Acid in Subjects With Primary Biliary Cholangitis

NCT05751967 ·Status: RECRUITING ·Phase: PHASE3

A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis

NCT02932449 ·Status: COMPLETED

Saroglitazar Magnesium for Treatment of Primary Biliary Cholangitis

NCT05133336 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Ursodeoxycholic Acid Combined With Low Dose Glucocorticoid in the Treatment of PBC With AIH Features II

NCT04617561 ·Status: UNKNOWN ·Phase: PHASE4

Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects With Primary Biliary Cholangitis

NCT05104853 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Clinical Research of Tapering UDCA in PBC Patients With a Complete Response

NCT04650243 ·Status: RECRUITING ·Phase: PHASE4

Real-World Data Study to Evaluate the Effectiveness of OCA on Hepatic Outcomes in PBC Patients

NCT05292872 ·Status: COMPLETED

Low-Dose Oral Methotrexate Versus Colchicine for Primary Biliary Cirrhosis

NCT00004748 ·Status: COMPLETED ·Phase: PHASE3

Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC)

NCT04526665 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Efficacy and Safety of Bezafibrate 400 mg and Bezafibrate 200 mg as Adjunctive Treatments in Patients With Primary Biliary Cholangitis and Non-optimal Biochemical Response to Ursodeoxycholic Acid Therapy

NCT06443606 ·Status: RECRUITING ·Phase: PHASE3

Ezetimibe-Ursodiol Combination Therapy on Biomarkers of Liver Function and Sterol Balance in Subjects With NAFLD

NCT02244944 ·Status: TERMINATED ·Phase: PHASE2

Trial of Psychoeducational and Hypnosis Interventions on the Fatigue Associated With PBC in Women

NCT03630718 ·Status: COMPLETED ·Phase: NA

Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis: a Real World Study

NCT06755541 ·Status: RECRUITING ·Phase: PHASE3

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Repeat Doses of GSK2330672 Administration in Subjects With Primary Biliary Cirrhosis (PBC) and Symptoms of Pruritus

NCT01899703 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis

NCT03394924 ·Status: COMPLETED ·Phase: PHASE2

Pilot Study of Budesonide for Patients With Primary Sclerosing Cholangitis

NCT00004842 ·Status: COMPLETED ·Phase: PHASE1

Ursodeoxycholic Acid Combined With Total Glucosides of Paeony in the Treatment of PBC With AIH Features 1

NCT04618575 ·Status: UNKNOWN ·Phase: PHASE4

Phase 2 Study of NGM282 in Patients With Primary Biliary Cirrhosis

NCT02026401 ·Status: COMPLETED ·Phase: PHASE2